603102 Weihai Baihe Biology Technological
- 32.72
- -0.44-1.33%
Weihai Baihe Biology Technological News
Lily Shares (603102.SH) will pay 7.5 yuan for every 10 shares in 2023. The share registration date is May 31
Lily Co., Ltd. (603102.SH) announced that the company will implement the 2023 annual equity distribution to all shares...
Changes in A-shares | Lily shares fell 7%, Q1 net profit fell 22% year on year
Gelonghui, April 12 | Lily Shares (603102.SH) closed down 7% at noon to 3.495 yuan, with a total market value of 2.24 billion yuan. The company announced yesterday after the market that revenue for the first quarter was 189 million yuan, down 18.68% year on year; net profit to mother was 35.85 million yuan, down 22.18% year on year; after deducting non-net profit of 34.73 million yuan, down 20.46% year on year. It is reported that the company will hold a shareholders' meeting on May 8.
Lily Co., Ltd. (603102.SH) announced first-quarter results, net profit of 35.85 million yuan, a year-on-year decrease of 22.18%
Lily Co., Ltd. (603102.SH) disclosed its report for the first quarter of 2024. During the reporting period, the company achieved revenue of 189 million yuan, a year-on-year decrease of 18.68%; net profit to mother of 34.85 million yuan, a year-on-year decrease of 22.18%; deducted non-net profit of 34.73 million yuan, a year-on-year decrease of 20.46%; and basic earnings per share of 0.54 yuan.
Lily Co., Ltd. (603102.SH): Net profit in 2023 increased by 22.65% year-on-year, and plans to pay 10 to 7.5 yuan
On April 11, Ge Longhui Co., Ltd. (603102.SH) announced its 2023 annual report. During the reporting period, it achieved operating income of 871 million yuan, an increase of 20.12%; net profit attributable to shareholders of listed companies was 169 million yuan, an increase of 22.65% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 163 million yuan, an increase of 22.34% year on year; and basic earnings per share. The company plans to distribute a cash dividend of 7.50 yuan (tax included) for every 10 shares to all shareholders.
Express News | The scheduled disclosure schedule for the first quarterly report of the Shanghai Stock Exchange was released, and Yongji Co., Ltd. and Meihua Biotech took the lead
Lily Shares (603102.SH): 1.59% of shares have been repurchased cumulatively
Gelonghui Co., Ltd. (603102.SH) announced on March 25, 2024, that as of March 23, 2024, the company had repurchased a total of 1.0204 million A-share common shares through the Shanghai Stock Exchange system, accounting for 1.59% of the company's current total share capital. The highest transaction price for the repurchase was RMB 39.50 yuan/share, the minimum transaction price was RMB 29.45 yuan/share, and the total amount of capital paid was RMB 388.432 million (excluding transaction fees such as stamp duty and transaction fees).
Lily Co., Ltd. (603102.SH): A total cost of 38.84 million yuan to buy back 1.59% of the shares
Gelonghui Co., Ltd. (603102.SH) announced on March 4, 2024, that as of February 29, 2024, the company had repurchased 1,020,400 shares of the company's shares through centralized bidding transactions, accounting for 1.59% of the company's current total share capital. The highest transaction price of the repurchase was RMB 39.50 per share, the minimum transaction price was RMB 29.45 per share, and the total amount of capital paid was RMB 38,843,216.76.
Following Recent Decline, Weihai Baihe Biology Technological Co., Ltd.'s (SHSE:603102) Top Shareholder CEO Xinli Liu Sees Holdings Value Drop by 17%
Key Insights Weihai Baihe Biology Technological's significant insider ownership suggests inherent interests in company's expansion A total of 5 investors have a majority stake in the company with 51
Lily Shares (603102.SH): Repurchase 1 million shares as of January 31
Gelonghui Co., Ltd. (603102.SH) announced on February 1, 2024, that as of January 31, 2024, the company had repurchased 1 million shares of the company's A-share common stock through centralized bidding transactions, accounting for 1.56% of the company's total share capital. The highest transaction price for the repurchase was RMB 39.50 yuan/share, the minimum transaction price was RMB 36.94 yuan/share, and the total amount of capital paid was RMB 38.2371 million (excluding transaction fees such as stamp duty and transaction fees).
Lily Co., Ltd. (603102.SH): A total cost of 38.237 million yuan to buy back 1.56% of the shares
Gelonghui Co., Ltd. (603102.SH) announced on January 2, 2023, that as of December 31, 2023, the company had repurchased 1,000,000 shares of the company's shares through centralized bidding transactions, accounting for 1.56% of the company's current total share capital. The highest transaction price of the repurchase was RMB 39.50 per share, the lowest transaction price was RMB 36.94 per share, and the total capital paid was RMB 38,237,128.76.
Lily Co., Ltd. (603102.SH): Smart factories for new marine functional drinks and oral liquids have been put into operation one after another
On December 25, Gelonghui Co., Ltd. (603102.SH) stated on the investor interactive platform that smart factories for new marine functional drinks and oral liquids have been put into operation one after another, and the current production capacity can meet market business needs.
Lily Co., Ltd. (603102.SH): Guangfa Sindh Bulk Trading has reduced its holdings by a cumulative total of 1.01%, and the share reduction plan has been implemented
Gelonghui Co., Ltd. (603102.SH) announced on December 25|Lily Co., Ltd. () announced that as of the disclosure of this announcement, Guangfa Sindh had reduced its holdings of the company by a total of 644,100 shares through bulk transactions, accounting for 1.01% of the company's total share capital. After this equity change, its overall shareholding ratio fell to 0.00%, and the implementation of this holdings reduction plan has been completed.
Lily Co., Ltd. (603102.SH): Repurchased 1.17% of shares at a cumulative cost of RMB 288.17,500
Gelonghui Co., Ltd. (603102.SH) announced on December 18, 2023, that as of December 18, 2023, the company has repurchased 750,400 shares of the company's A-share common stock through centralized bidding through the Shanghai Stock Exchange system, accounting for 1.17% of the company's current total share capital, an increase of 0.37% compared with the previous disclosure. The maximum transaction price of the repurchase price is RMB 39.50 per share, and the minimum transaction price is RMB 37.61 per share. The total capital paid is RMB 28,817,514.
Company Q&A丨Lily Shares: Currently, the company's large single products are in good demand
Gelonghui, November 27 | Some investors asked Baihe Co., Ltd. on an interactive platform: How was the company's major single product sales in the third and fourth quarter of this year? Lily Co., Ltd. responded: Currently, demand for the company's large single products is good. At present, the large single products of Lily Co., Ltd. -- Baihekang brand glucosamine sulfate calcium capsules and Hongyangshen brand blueberry lutein beta-carotene softgels have relatively high market recognition and share, and have certain promotion advantages. Currently, the company's orders and sales conditions are normal.
Lily Co., Ltd. (603102.SH): Repurchased 0.8% of shares at a cumulative cost of 1,929,000 yuan
Glonghui Co., Ltd. (603102.SH) announced on October 31, 2023, that as of October 31, 2023, the company has repurchased a total of 512,500 shares of the company's shares through centralized bidding, accounting for 0.80% of the company's current total share capital. The maximum repurchase price is RMB 39.50 yuan/share, the lowest transaction price is RMB 37.61 per share, and the total capital paid is RMB 19,729,153.00.
[Instant Analysis of BT Financial Report] Lily Co., Ltd.'s 2023 three-quarter report: Operating income and net profit continued to grow, and cash flow increased significantly
Announcement time of this financial report: 2023-10-24 15:55:29 Lily Co., Ltd. (stock code: 603102) is a company focusing on the nutritional health food industry, with rich market experience and professional knowledge. The company actively participates in raw material innovation research and strictly complies with GMP review standards to ensure product safety and quality. Driven by the national health strategy, the company will continue to commit to the development of national health services and meet new challenges and opportunities. In terms of assets and liabilities, the total assets of Baihe Co., Ltd. at the end of the third quarter of 2023 reached 1,713 billion yuan, compared to the end of the previous year
Lily Co., Ltd. (603102.SH) released results for the first three quarters, with net profit of 129 million yuan, an increase of 20.68% over the previous year
Lily Co., Ltd. (603102.SH) disclosed the report for the third quarter of 2023. The company achieved revenue of 6 in the first three quarters...
Lily Shares (603102.SH) has passed half of the repurchase period and has not yet implemented a repurchase
Lily Co., Ltd. (603102.SH) announced that as of the disclosure date of this announcement, the implementation period for this share repurchase has passed halfway,...
Lily Co., Ltd. (603102.SH): Produces products with weight loss and health care functions
Gelonghui September 15 | Lily Co., Ltd. (603102.SH) said on the investor interactive platform that the company produces products with weight loss and health benefits, such as Hongyang Shenbrand Lotus Leaf Diazepam tablets and Baihekang L-carnitine aloe vera tablets.
Lily Shares (603102.SH): The company's shares have not been repurchased through centralized bidding transactions
Glonghui, August 31, 丨 Lily Co., Ltd. (603102.SH) announced that as of August 31, 2023, the company had not repurchased the company's shares through centralized bidding transactions.
Analysis
Price Target
No Data
